DLHCX Fees and Costs — Nomura Healthcare Fund, Class C
Data updated: 2026-08-26
The net expense ratio is 1.96%: a 0.84% management fee, a 1.00% 12b-1 fee plus 0.17% other expenses, less a 0.05% fee waiver. This share class carries a deferred sales charge of up to 1.00%. In fiscal 2026 the fund paid $78K in broker commissions, 0.0116% of average net assets, and portfolio turnover was 4%.
DLHCX Fees and Expenses
Annual operating expenses and sales charges of DLHCX. Prospectus, as of March 31, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.84% |
| 12b-1 fee | 1.00% |
| Other expenses | 0.17% |
| Gross expense ratio | 2.01% |
| Fee waiver | −0.05% |
| Net expense ratio | 1.96% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 1.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
DLHCX Costs Over Time
On $10,000 invested in DLHCX, assuming 5% a year before costs, total costs come to $1,210 over 5 years, cutting the return by 2.07% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $103 | $0 | $0 |
| Fund expenses (net expense ratio 1.96%) | $206 | $636 | $1,091 |
| Trading costs (broker commissions) | $1 | $4 | $6 |
| Lost growth on money paid in costs | $0 | $32 | $112 |
| Total costs | $310 | $671 | $1,210 |
| Value after costs | $10,190 | $10,905 | $11,553 |
| Impact on return, per year | 3.10% | 2.07% | 2.07% |
DLHCX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0116%
- Total broker commissions: $78K
- Bought from dealers (principal trades, not a cost): $4.6M
- Portfolio turnover (prospectus): 4%
- Securities lending: none during the year
DLHCX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| GOLDMAN SACHS & CO. LLC | $11K | 16.50% |
| J.P. Morgan Securities LLC | $9K | 13.31% |
| HSBC SECURITIES (USA) INC. | $9K | 12.85% |
| BOFA SECURITIES, INC. | $8K | 12.34% |
| JONESTRADING | $6K | 9.48% |
| UBS Securities LLC | $6K | 9.32% |
| CANTOR FITZGERALD & CO. | $6K | 8.93% |
| JEFFERIES LLC | $4K | 6.19% |
| TD SECURITIES (USA) LLC | $4K | 5.75% |
| VIRTU AMERICAS LLC | $4K | 5.34% |
DLHCX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| GOLDMAN SACHS & CO. LLC | $4.6M | 100.00% |
Nomura Healthcare Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| DLHIX | Institutional Class | 0.96% | none |
| DLHAX | Class A | 1.21% | 5.75% |
| DLRHX | Class R | 1.46% | none |
| DLHCX | Class C | 1.96% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.